These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8133539

  • 1. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas.
    Drobnjak M, Latres E, Pollack D, Karpeh M, Dudas M, Woodruff JM, Brennan MF, Cordon-Cardo C.
    J Natl Cancer Inst; 1994 Apr 06; 86(7):549-54. PubMed ID: 8133539
    [Abstract] [Full Text] [Related]

  • 2. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
    Jensen V, Sørensen FB, Bentzen SM, Ladekarl M, Nielsen OS, Keller J, Jensen OM.
    Histopathology; 1998 Jun 06; 32(6):536-46. PubMed ID: 9675593
    [Abstract] [Full Text] [Related]

  • 3. p53/MDM-2 immunohistochemical expression correlated with proliferative activity in different subtypes of human sarcomas: a ten-year follow-up study.
    Stefanou DG, Nonni AV, Agnantis NJ, Athanassiadou SE, Briassoulis E, Pavlidis N.
    Anticancer Res; 1998 Jun 06; 18(6B):4673-81. PubMed ID: 9891539
    [Abstract] [Full Text] [Related]

  • 4. High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities.
    Würl P, Meye A, Schmidt H, Lautenschläger C, Kalthoff H, Rath FW, Taubert H.
    Oncogene; 1998 Mar 05; 16(9):1183-5. PubMed ID: 9528860
    [Abstract] [Full Text] [Related]

  • 5. Expression of P53, MDM2 and Ki-67 antigens in soft tissue sarcomas.
    Szadowska A, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    Pol J Pathol; 1999 Mar 05; 50(1):9-16. PubMed ID: 10412269
    [Abstract] [Full Text] [Related]

  • 6. [p53 overexpression as independent prognostic marker in soft tissue sarcomas is antibody dependent].
    Würl P, Taubert H, Meye A, Berger D, Holzhausen HJ, Schmidt H, Hinze R, Rath FW, Schönfelder M.
    Verh Dtsch Ges Pathol; 1998 Mar 05; 82():358-61. PubMed ID: 10095460
    [Abstract] [Full Text] [Related]

  • 7. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas.
    Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF, Levine AJ.
    Cancer Res; 1994 Feb 01; 54(3):794-9. PubMed ID: 8306343
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
    Choong PF, Akerman M, Willén H, Andersson C, Gustafson P, Baldetorp B, Fernö M, Alvegård T, Rydholm A.
    APMIS; 1994 Dec 01; 102(12):915-24. PubMed ID: 7888160
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P, Bartkowiak JK, Szadowska AM, Olborski B, Harezga-Bal B, Debiec-Rychter M.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):403-16. PubMed ID: 10606188
    [Abstract] [Full Text] [Related]

  • 10. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
    Folpe AL, Lyles RH, Sprouse JT, Conrad EU, Eary JF.
    Clin Cancer Res; 2000 Apr 01; 6(4):1279-87. PubMed ID: 10778952
    [Abstract] [Full Text] [Related]

  • 11. Prognostic implication of the p53 protein and Ki-67 antigen immunohistochemistry in malignant fibrous histiocytoma.
    Yang P, Hirose T, Hasegawa T, Seki K, Sano T, Hizawa K.
    Cancer; 1995 Aug 15; 76(4):618-25. PubMed ID: 8625155
    [Abstract] [Full Text] [Related]

  • 12. Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.
    Ellison DW, Steart PV, Bateman AC, Pickering RM, Palmer JD, Weller RO.
    J Neurol Neurosurg Psychiatry; 1995 Oct 15; 59(4):413-9. PubMed ID: 7561922
    [Abstract] [Full Text] [Related]

  • 13. Expression of p53 gene product and cell proliferation marker Ki-67 in Ewing's sarcoma: correlation with clinical outcome.
    Amir G, Issakov J, Meller I, Sucher E, Peyser A, Cohen IJ, Yaniv I, Ben Arush MW, Tavori U, Kollender Y, Ron N, Peylan-Ramu N.
    Hum Pathol; 2002 Feb 15; 33(2):170-4. PubMed ID: 11957141
    [Abstract] [Full Text] [Related]

  • 14. Prognostic relevance of a histological grading system using MIB-1 for adult soft-tissue sarcoma.
    Hasegawa T, Yokoyama R, Lee YH, Shimoda T, Beppu Y, Hirohashi S.
    Oncology; 2000 Feb 15; 58(1):66-74. PubMed ID: 10644943
    [Abstract] [Full Text] [Related]

  • 15. Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery.
    Bode-Lesniewska B, Zhao J, Speel EJ, Biraima AM, Turina M, Komminoth P, Heitz PU.
    Virchows Arch; 2001 Jan 15; 438(1):57-65. PubMed ID: 11213836
    [Abstract] [Full Text] [Related]

  • 16. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M, Leonardi E, Mauri FA, Serio G, Dalla Palma P.
    Am J Clin Pathol; 1992 Oct 15; 98(4):408-18. PubMed ID: 1357956
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas.
    Golouh R, Bracko M, Novak J.
    Mod Pathol; 1996 Sep 15; 9(9):919-24. PubMed ID: 8878024
    [Abstract] [Full Text] [Related]

  • 18. Beta-catenin in soft tissue sarcomas: expression is related to proliferative activity in high-grade sarcomas.
    Kuhnen C, Herter P, Müller O, Muehlberger T, Krause L, Homann H, Steinau HU, Müller KM.
    Mod Pathol; 2000 Sep 15; 13(9):1005-13. PubMed ID: 11007041
    [Abstract] [Full Text] [Related]

  • 19. Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor.
    Kawai A, Noguchi M, Beppu Y, Yokoyama R, Mukai K, Hirohashi S, Inoue H, Fukuma H.
    Cancer; 1994 May 15; 73(10):2499-505. PubMed ID: 8174045
    [Abstract] [Full Text] [Related]

  • 20. Expression of p53 and proliferation index as prognostic factors in gastrointestinal sarcomas.
    Medina-Franco H, Ramos-De la Medina A, Cortes-Gonzalez R, Baquera J, Angeles-Angeles A, Urist MM, Eltoum IE, Heslin MJ.
    Ann Surg Oncol; 2003 Mar 15; 10(2):190-5. PubMed ID: 12620916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.